Thomas Lee
Thomas Lee was the Minnesota Bureau Chief for MedCityNews.
-
Venture capitalist abandons effort to create Minnesota early stage fund(?)
Fund founder Jim O’Reilly says it was “fairly impossible” to raise money. For O’Reilly, explaining Upwind to potential investors proved to be a challenge in itself. For one thing, O’Reilly insisted Upwind was not a “fund” but rather a “new model” for developing startups.
-
Minnesota maker of biotech containers raises over $1m
Applied Bioprocess Containers LLC has raised $1.03 million from the sale of equity, about $30,000 shy of its goal, according to documents filed with the Securities and Exchange Commission.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Nascent Surgical raises $200,000 for smoke filtering device
Nascent Surgical LLC raised $223,000 from the sale of equity, according to documents filed with the Securities and Exchange Commission.
-
Biolyst wants $1m plus to franchise laser treatment for nerve disease
Biolyst LLC is seeking $1.25 million from the sale of equity and warrants, according to documents filed with the Securities and Exchange Commission.
-
New hearing aid designed to boost amplification, reduce wind noise
The hearing aid system is supposed to boost the outer ear’s natural ability to direct and amplify high frequency sound and reduce wind noise. It’s made by ReSound, a medical device company based in Bloomington, Minnesota. The company said the Remote Microphone Technology provides users a more appealing cosmetic look by tucking the microphone in the concha cymba area of the external ear.
-
Riverside Co. buys St. Paul software maker CareFacts Information Systems
Private equity firm Riverside Co. has acquired CareFacts Information Systems, based in St. Paul, Minnesota, for an undisclosed amount.
-
Minnesota legislative preview: For healthcare, defense is the best offense
Life science current events will collide with political realities in Minnesota. Last year the medical industry made important strides, including winning an angel investment tax credit. This year healthcare interests will likely be on the defensive. The University of Minnesota, the Biomedical Discovery District and health services for the poor are on the chopping block.
-
Morgan Stanley downgrades St. Jude Medical, citing slower ICD business
In his research report, Morgan Stanley analyst David Lewis says St. Jude faces significant challenges — both big picture and small picture.
-
Medtronic’s Bill Hawkins’ (brief) tenure as CEO
Medtronic (NYSE:MDT) announced this week that CEO Bill Hawkins will retire in April 2011 after just three-plus years on the job. While his tenure was relatively short, Hawkins left an indelible mark on the world’s largest maker of new innovative medical devices. Here’s a look back on the Hawkins era at Medtronic.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
University of Minnesota researchers discover potential HIV block
The University of Minnesota said its scientists have discovered a possible way to stop the spread of the virus that causes AIDS by preventing the pathogen from attaching itself to an antiviral protein. APOBEC3F belongs to a family of proteins that defend the body against viruses. The HIV virus, however, has developed an ability to attach itself to the protein and destroy it.
-
GT Urological raises nearly $5m for urinary incontinence device
GT Urological has raised $4.56 million from the sale of equity, according to documents filed with the Securities and Exchange Commission.
-
Vaccines and Viruses: Best, worst of Minnesota medical in 2010
Thank God for St. Jude Medical, pro-investment legislators and hearing device companies plugged by Rush Limbaugh. Thumbs down to Boston Scientific, a diminishing amount of venture capital and boondoggle business parks.
-
University of Minnesota researchers link tau to Alzheimer’s disease
The University of Minnesota said Wednesday that scientists have established a firm relationship between a […]
-
BridgePoint Medical raises $9M for device to unblock blood vessels
BridgePoint Medical Inc. has raised $9.1 million from the sale of equity. The company based in Plymouth, Minnesota, is developing balloon catheter system to treat chronic coronary and peripheral total occlusions, a condition in which clots frequently clog blood vessels.
-
Medtronic wins FDA approval for stent graft to treat abdominal aneurysms
The FDA approval of the Endurant system adds yet another stent to the list of Medtronic’s cadriovascular products. The company is relying on new innovative medical devices to continue to grow revenue. Medtronic estimates 1.2 million Americans suffer from abdominal aortic aneurysms, which will be treated by Endurant.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
